Abstract 15643: Is Bleeding Risk Augmented With Acute Therapies Across Increasing INR Levels Among NSTEMI Patients on Home Warfarin Therapy?
Sumeet Subherwal(Washington University in St. Louis), Tracy Y Wang(Duke Medical Center), Karen P. Alexander(Clinical Research Institute), Brian F. Gage(Washington University in St. Louis), Deepak L. Bhatt(Mount Sinai Hospital), Anita Y. Chen(University of Rochester Medicine), Jeffrey B. Washam(Jeffrey Modell Foundation), Richard G. Bach(Washington University in St. Louis), Stephen D. Wiviott(Brigham and Women's Hospital), Eric D. Peterson(The University of Texas Southwestern Medical Center), Matthew T. Roe(Clinical Research Institute)
Circulation
November 23, 2010
Cited by 0
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k